KARBF Stock: Karo Pharma AB (publ) Stock Price, Analysis & Insights
Get live KARBF stock price $5.25, comprehensive Karo Pharma AB (publ) stock analysis, charts, news, and expert forecast. Real-time KARBF stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Headquartered in Stockholm, Sweden, Karo Pharma AB (publ) specializes in the development and commercialization of both prescription pharmaceuticals and over-the-counter (OTC) health products. These offerings reach pharmacies and retail sectors across...
Company Information
- CEO
- Christoffer Lorenzen
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 225
Contact Information
- Website
- https://www.karopharma.com
- Address
- Klara Norra Kyrkogata 33
- Country
- SE
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 262.5)
✓ Lower volatility stock (Beta: 0.00) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Karo Pharma AB (publ) shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Karo Pharma AB (publ)
- ⚠Investors should consider how Karo Pharma AB (publ) fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 262.5) requires strong growth to justify
Market Cap
1.52B
P/E Ratio (TTM)
262.50
Beta
0.00
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare KARBF with peer companies:
- Price
- $32.00
- Market cap
- 1.60B
- Price
- $15.01
- Market cap
- 1.20B
- Price
- $23.00
- Market cap
- 1.19B
- Price
- $33.66
- Market cap
- 1.74B
- Price
- $1.00
- Market cap
- 758.42M
- Price
- $83.00
- Market cap
- 1.56B
- Price
- $543.70
- Market cap
- 1.75B
- Price
- $26.00
- Market cap
- 984.58M
- Price
- $23.90
- Market cap
- 1.60B
- Price
- $9.96
- Market cap
- 1.62B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.